Interventional oncology is a rapidly growing field of interventional oncology which deals with diagnosis and treatment of cancer using minimally invasive procedures. It uses various imaging techniques such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. Interventional oncology is generally employed for treatment of liver cancer, lung cancer, bone cancer, kidney cancer, prostate cancer, breast cancer, and pancreatic cancer. Interventional oncology treatment market is segmented into Radiation therapy, Ablation, and Particle embolization on the basis of procedure.
Interventional oncology is expected to become the fourth pillar of cancer care, with medical, surgical, and radiation oncology. It provides with minimally invasive treatment option while mitigating various associated risks. Growth of the global interventional oncology market is propelled by rising oncology incidences, growing demand for minimally invasive therapeutics and increasing geriatric population. However, the market faces several challenges due to high treatment cost, associated risk, and the presence of alternative treatment options.
The report “Global Interventional Oncology Market – (By Therapy – Radiation Therapy, Particle Embolization & Ablation; By Region- North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global interventional oncology market with coverage on major market segments such as Radiation Therapy, Particle Embolization & Ablation. Future forecasts of interventional oncology market overall and across various market segments have been provided in the report till 2025. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global interventional oncology market include Boston Scientific Corporation, Accuray Incorporated, Medtronic PLC, Terumo Corporation, Merit Medical Systems, Inc., BTG PLC, among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global interventional oncology market.
Key Factors Impacting Market Growth:
- Rising oncology incidences
- Growing demand for minimally invasive therapeutics
- Increasing geriatric population
North America, Western Europe, and Asia Pacific by region are estimated to dominate the interventional oncology market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for interventional oncology market during the forecast period.
The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for interventional oncology market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for interventional oncology market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for interventional oncology during the forecast period.
Companies Covered: Boston Scientific Corporation, Accuray Incorporated, Medtronic PLC, Terumo Corporation, Merit Medical Systems, Inc., BTG PLC
- Radiation Therapy
- Particle Embolization
- North America
- Asia Pacific
- Rest of the World
Reasons To Buy This Report:
- Market size estimation of the Global Interventional Oncology market on a regional and global basis
- The unique research design for market size estimation and forecast
- Profiling of major companies operating in the market with key developments
- Broad scope to cover all the possible segments helping every stakeholder in the market
We provide customization of the study to meet specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
For more information, contact: [email protected]